Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
ChAdOx1 MERS候选疫苗在健康中东成年人中的安全性和免疫原性(MERS002):一项开放标签、非随机、剂量递增的1b期试验
期刊:Lancet Microbe
影响因子:20.4
doi:10.1016/S2666-5247(21)00193-2
Bosaeed, Mohammad; Balkhy, Hanan H; Almaziad, Sultan; Aljami, Haya A; Alhatmi, Hind; Alanazi, Hala; Alahmadi, Mashael; Jawhary, Ayah; Alenazi, Mohammed W; Almasoud, Abdulrahman; Alanazi, Rawan; Bittaye, Mustapha; Aboagye, Jeremy; Albaalharith, Nahla; Batawi, Sarah; Folegatti, Pedro; Ramos Lopez, Fernando; Ewer, Katie; Almoaikel, Khalid; Aljeraisy, Majed; Alothman, Adel; Gilbert, Sarah C; Khalaf Alharbi, Naif